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Exposure of the heart during radiotherapy poses increased risk for developing radiation-induced heart disease (RIHD), which is of concern in long-term cancer survivors (1, 2) . Indicators of RIHD include conduction abnormalities, injury to cardiac valves, pericardial and myocardial fibrosis and accelerated atherosclerosis, most of which take from several years to decades to present (3, 4) . The mechanisms by which radiation causes late cardiac injury are not yet fully understood.
We have previously shown that local heart irradiation in a rat model caused enhanced mitochondrial permeability transition pore (mPTP) opening within hours after irradiation and lasting for several months. Moreover, mitochondria isolated from irradiated hearts showed reduced ex vivo basal (state 2) respiration when tested in the presence of respiratory complex II substrate succinate combined with the complex I inhibitor rotenone. Respiration was not altered in the presence of complex I substrates glutamate and malate. Moreover, we showed that mitochondrial tetramethylrhodamine methyl ester (TMRM) uptake was reduced, indicative of reduced mitochondrial membrane potential, at time points up to two weeks after irradiation (5) . The exact role of these mitochondrial changes in the pathophysiology of RIHD remains to be determined.
The natural vitamin E analogs, tocotrienols, have emerged as some of the strongest radiation protectors of all natural compounds that have been tested so far (6, 7) . 2 Moreover, tocotrienols have particular properties that may make them effective against cardiovascular disease. While tocotrienols have antioxidant properties as strong as a-tocopherol (8), they accumulate in endothelial cells to at least 30-fold higher levels than a-tocopherol and modulate at least 20-fold larger numbers of genes in endothelial cells (9, 10) . Moreover, c-and d-tocotrienols reduce the intracellular levels of 3-hydroxy-3-methylglutaryl-coenzyme A (HMGCoA) reductase, the rate-limiting enzyme in cholesterol biosynthesis (11, 12) . Lastly, a recent study has shown that tocotrienols protect against oxidative stress-induced mitochondrial dysfunction (13) . In the current study, we examined the effects of tocotrienols on radiation-induced mitochondrial changes and functional and structural manifestations of RIHD in our rat model of local heart irradiation.
All forms of vitamin E are fat soluble, which hampers their absorption in the gut upon oral administration. Tocomin SupraBiot (TSB) is a tocotrienol-enriched extract from palm oil that contains 17% tocotrienols (8% ctocotrienol, 5% a-tocotrienol, 3% d-tocotrienol, 1% btocotrienol) and 5% a-tocopherol in a self-emulsifying delivery system designed for enhanced oral absorption (14) . We have previously shown that oral administration of TSB in our rat model caused significant increases in plasma levels of all forms of vitamin E present in the TSB mixture (15) . Tocotrienols and tocopherols may have anticancer activities and may also radiosensitize cancer cells (16) (17) (18) . Nonetheless, administering any radiation protection compound before the onset of radiotherapy may not be preferable because of potential interactions with the effects of radiation on the tumor cells. However, since previous studies suggest that tocotrienols are most effective when administered 24 h before irradiation (6, (19) (20) (21) , the main goal of this study was to first provide proof of principle by testing the effects of TSB when administered 24 h before irradiation.
MATERIALS AND METHODS

Animal Model and Administration of TSB
All procedures in this study were approved by the Institutional Animal Care and Use Committee of the University of Arkansas for Medical Sciences. Male Sprague-Dawley rats (Harlant Laboratories Inc., Indianapolis, IN) were maintained in our Division of Laboratory Animal Medicine on a 12:12 light-dark schedule with free access to food and water. Upon reaching a weight of 250-290 g, the rats were administered 500 ll of TSB, translating to 230 mg tocotrienols/kg body weight or 500 ll vehicle (self-emulsifying formulation), via oral gavage 24 h before local heart irradiation. TSB and vehicle were kindly provided by Carotech BHD. (Perak, Malaysia).
Local Heart Irradiation
Rats received local heart irradiation with the Small Animal Conformal Radiation Therapy device (SACRTD) developed at our institution. The SACRTD consists of a 225 kVp X-ray source (GE Isovolt Titan 225, GE Sensing and Inspection Technologies, Billerica, MA) mounted on a custom-made ''gantry'', a stage mounted on a robotic arm positioning system (Vipere s650, Adept Technology Inc., Pleasanton, CA), and a flat panel digital X-ray detector of 200 lm resolution (XRD 0820 CM3, PerkinElmert Inc., Waltham, MA). For the purpose of local heart irradiation, a brass and aluminum collimating assembly was attached to the X-ray tube to produce a 19 mm diameter field at the isocenter (22) .
Dosimetry was performed with a PinPointt chamber (PTW N301013, PTW, Freiburg, Germany; ADCL calibrated for 225 kV) and Gafchromict EBT-2 films (Ashlandt Inc., Covington, KY) placed in a solid water phantom as previously described (23) . For local heart irradiation, rats were anesthetized with 3% isoflurane and placed vertically in a cylindrical Plexiglas holder that was cut out to remove any Plexiglas material between the radiation beam and the chest. The heart was exposed in three 19 mm diameter fields (anterior-posterior and two lateral fields) of 7 Gy each (225 kV, 13 mA, 0.5 mm Cu filtration resulting in 1.92 Gy/min at 1 cm tissue depth). We previously showed that a cardiac dose of 21 Gy in Sprague-Dawley rats caused changes in left ventricular (LV) mitochondria, intracellular signaling molecules and moderate long-term changes in cardiac function and structure (5, 15, 24) . The three doses of 7 Gy were given immediately after each other. Before each exposure the location of the heart was verified with the X-ray detector (70 kV, 5 mA, ,1 cGy) and, if necessary, the position of the rat was adjusted with the use of the robotic arm. The cardiac targeting of the heart is shown in Supplementary Fig. S1 (http://dx.doi.org/10.1667/RR13915.1.S1) and has been previously described by our group (22) .
Rats were sacrificed at 2 and 28 weeks after local heart irradiation, and the hearts were collected for analysis. The 2 week time point consisted of four experimental groups: sham-irradiated vehiclepretreated, sham-irradiated TSB-pretreated, irradiated vehicle-pretreated and irradiated TSB-pretreated (5 animals per group). The 28 week time point consisted of three experimental groups: sham-irradiated vehicle-pretreated, irradiated vehicle-pretreated and irradiated TSBpretreated (9-10 animals per group).
Echocardiography
Echocardiography (ECGs) was performed as described previously (25) , using a Vevot 2100 imaging system (VisualSonics Inc., Toronto, Canada) with the MS250 transducer (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . Animals were anesthetized with 1.5-2% isoflurane and hair was removed from the chest with clippers followed by a depilatory cream. The rats were placed on a warmed platform that recorded ECGs from the paws. ECGs were used to detect bradycardia (heart rate ,250 bpm) and arrhythmia. Short axis M-mode recordings at the mid-LV level were used to obtain LV anterior wall (LVAW), posterior wall (LVPW), inner diameter (LVID), ejection fraction (EF), fractional shortening (FS), stroke volume, cardiac output and heart rate.
High-Performance Liquid Chromatography Quantification of Glutathione
High-performance liquid chromatography with electrochemical detection (HPLC-ECD) was used to evaluate levels of reduced glutathione (GSH) and oxidized glutathione (GSSG). Details of this method have been previously described (26) . In short, approximately 50 mg of tissue was minced and homogenized in 500 ll of ice-cold phosphate buffered saline. To precipitate proteins, 150 ll of 10% metaphosphoric acid was added to 100 ll of tissue homogenate and incubated for 30 min on ice. The samples were then centrifuged at 18,000g at 48C for 15 min, and 20 ll of the resulting supernatants were injected into the HPLC column for metabolite quantification, while the pellet underwent protein analysis using a BCA protein assay (Sigma-Aldricht LLC, St. Louis, MO). Free protein-unbound GSH and GSSG were separated by HPLC-ECD coupled with a solvent delivery system (model no. 580E, ESA Inc., Chelmsford, MA). A reverse phase C 18 Shisheido column (3 l; 4.6 3 150 mm) was obtained from Phenomenext Inc. (Torrance, CA). Isocratic elution with a mobile phase consisting of 50 mM sodium phosphate monobasic, monohydrate, 1.0 mM ion-pairing reagent OSA, 4% acetonitrile (v/v), adjusted to pH 2.7 with 85% phosphoric acid, was performed at ambient temperature at a flow rate of 1.0 mL/min and a pressure of 120-140 kgf/cm 2 (1,800-2,100 psi). Tissue homogenates were directly injected onto the column using an ESA Autosampler (model no. 507E). The results are expressed as nM per mg total protein.
Ex Vivo Analysis of Mitochondria
Mitochondrial respiration, mPTP opening and measurement of mitochondrial membrane potential were performed as described before (5) . In short, rats were anesthetized with 3% isoflurane, the heart was isolated, and 180-200 mg of LV tissue was immediately minced and homogenized in 10 mL of a 10 mM HEPES buffer containing 225 mM mannitol, 75 mM sucrose, 1 mM EGTA and 0.5% (w/v) fatty acid-free BSA (pH 7.4) using a mechanical Dounce homogenizer with a Teflon pestle. The homogenate was centrifuged at 700g for 10 min at 48C, and the supernatant collected and centrifuged at 12,500g for 30 min to obtain the mitochondrial pellet. Mitochondria were used immediately to measure mitochondrial respiration, mPTP opening and mitochondrial membrane potential, as described previously (5).
Mitochondrial respiration was analyzed with an XF96 Extracellular Flux Analyzer (Seahorse Bioscience, North Billerica, MA). Mitochondria were placed in an XF96 microplate, 10 or 15 lg mitochondrial mass per well (8 wells for each), and mixed with 10 mM succinic acid and 0.2 lM rotenone. The plates were centrifuged at 48C, 2,000g for 20 min to attach the mitochondria to the bottom of the wells, then incubated at 378C for 10 min and transferred to the XF96 Extracellular Flux Analyzer. Four baseline measurements were acquired, followed by readings after sequential addition of ADP (4 lM), oligomycin (4 lM), p-trifluoromethoxyphenylhydrazone (FCCP) (4 lM) and antimycin A (10 lM). The oxygen consumption rate (OCR) was calculated with XF96 software. Each XF96 plate contained mitochondria from one heart of each experimental group, and within each plate the OCR of the irradiated mitochondria was calculated relative to the OCR of the sham-irradiated mitochondria.
To assess mPTP opening, mitochondria were washed in 10 mM HEPES buffer containing 395 mM sucrose and 0.1 mM EGTA to remove excess BSA. MPTP opening was then assessed in a swelling assay, in which mitochondria were resuspended in swelling buffer containing 120 mM KCl, 10 mM Tris HCl, and 5 mM KH 2 PO 4 and exposed to vehicle, 250 lM CaCl 2 or 250 lM CaCl 2 in combination with 2 lM cyclosporin A (CsA), as an inhibitor of transition pore opening. In another set of experiments mPTP opening was assessed by adding either 5 lM doxorubicin or 5 lM doxorubicin combined with 2 lM CsA. MPTP opening in response to CaCl 2 or doxorubicin will lead to mitochondrial swelling, which is detected by a reduction in optical density at 540 nm (OD540nm). Optical density at 540 nm was measured with a Synergye 4 microplate reader (BioTekt, Winooski, VT), immediately before the assay and every 2 min thereafter for a total of 20 min.
Mitochondrial membrane potential was assessed with TMRM, a cationic dye that accumulates in mitochondria in proportion to the mitochondrial membrane potential. Mitochondria were resuspended in 10 mM HEPES containing 395 mM sucrose and 0.1 mM EGTA, loaded with 50 nm or 200 nm TMRM and incubated at room temperature for 15 min. Mitochondria were centrifuged at 14,000 rpm for 3 min to remove excess TMRM, and the fluorescence intensity of the mitochondrial pellets was determined at 590 nm in a Synergy 4 microplate reader (BioTek) and normalized to mitochondrial protein content as measured with a BCA protein assay. Each isolation of mitochondria included one heart from each experimental group, and the normalized TMRM signals were calculated relative to the TMRM signal of the mitochondria from the sham-irradiated heart.
Western Blots
Western blots were performed as previously described (15, 27) . In short, LV tissue was homogenized in RIPA buffer with inhibitor cocktails of proteases (10 lL/mL) and phosphatases (10 lL/mL, both Sigma-Aldrich), centrifuged at 20,000g at 48C for 15 min, and the supernatant was collected. Similarly, mitochondria pellets were lysed with RIPA buffer containing protease and phosphatase inhibitors for 30 min with intermittent vortexing, followed by sonication for 6 s. The lysates were centrifuged at 14,000 rpm for 10 min and the supernatants were collected. Amounts of protein were determined with a BCA protein assay. A total of 50 lg protein was prepared in Laemmli sample buffer containing b-mercaptoethanol (1:20 vol/vol) and boiled for 2-3 min. Protein samples were separated in 4-20% TGXe MiniPROTEANt polyacrylamide gels and transferred to PVDF membranes (Bio-Rad Laboratories Inc., Hercules, CA).
Nonspecific antibody binding was reduced by TSB containing 0.05% Tween-20 and 5% nonfat dry milk. Membranes were then incubated overnight with rabbit anti-Bax, rabbit anti-Bcl2 (Santa Cruz Biotechnologyt Inc., Dallas, TX) or rabbit anti-caspase 3 (Cell Signaling Technologyt, Danvers, MA) both in TSB containing 5% nonfat dry milk and 0.1% Tween-20, followed by HRP conjugated mouse anti-rabbit (Cell Signaling Technology) or HRP-conjugated goat anti-mouse (Jackson ImmunoResearch Laboratories Inc., West Grove, PA). Protein loading was corrected by incubating membranes in mouse anti-GAPDH for whole tissue lysates (Santa Cruz Biotechnology, Inc.) or mouse anti-F0-F1 ATPase for mitochondrial lysates (Life Technologies, Grand Island, NY), followed by HRPconjugated goat anti-mouse. Antibody binding was visualized with ECLe Plus Western Blotting Detection reagent (GE Healthcare BioSciences, Pittsburgh, PA) on CL-Xposure Film (Thermo Fisher Scientific, Boston MA). Films were scanned using an AlphaImagert gel documentation system (ProteinSimplet, San Jose, CA) and protein bands were quantified with the public domain software ImageJ (National Institutes of Health, Bethesda, MD).
Histology
Hearts were fixed in 37% formaldehyde and embedded in paraffin. Histology and immunohistochemistry were performed as previously described (27) . In short, for determination of collagen deposition and areas of myocardial degeneration, sections were deparaffinized, rehydrated and incubated in Sirius Red (American Master*Tech Scientific Inc., Lodi, CA) supplemented with Fast Green (Fisher Scientifice, Thermo Fisher Scientific Inc.). The sections were scanned with an Aperioe ScanScopet CS2 slide scanner and analyzed with Aperio ImageScope 12 software (both scanner and software from Leica Biosystems Imaging Inc., Nussloch, Germany) to determine the percentage tissue area positive for collagens.
To visualize mast cells, deparaffinized and rehydrated sections were incubated in 0.5% toluidine blue in 0.5 N HCl for 72 h, followed by 0.7 N HCl for 10 min. Mast cells were counted using an Axioskop transmitted light microscope (Carl Zeiss, Jena, Germany).
A lectin staining was used to determine microvascular density. Sections were deparaffinated and rehydrated, and antigen retrieval was performed by treating the sections with 10 mM sodium citrate (pH 6.0) at 958C for 20 min. Sections were allowed to cool down prior to incubation in 1% H 2 O 2 in methanol for 30 min to quench the endogenous peroxidase activity. Sections where then incubated with biotinylated Lycopersicon esculentum (tomato) lectin (1:200, Vector Laboratories, Burlingame, CA) for 90 min at room temperature. Lectin staining was visualized by incubating the sections in avidin-biotinperoxidase complex (Vector Laboratories) for 45 min at room temperature and then in 0.5 mg/ml DAB (Sigma-Aldrich) and 0.003% H 2 O 2 for 5 min. After counterstaining with hematoxylin, sections were dehydrated and mounted. Sections were then scanned with an Aperio ScanScope CS2 slide scanner and analyzed with Aperio ImageScope 12 software. Four fields were randomly selected to count the lectin-stained capillaries, and the total number of capillaries was divided by the area of the field to obtain capillary density. The average value of capillary density of each section was used as a single data point for statistical analysis.
Statistical Analysis
Data are shown as averages 6 standard error of the mean (SEM). Data were evaluated with two-way analysis of variance (ANOVA) or repeated measures ANOVA (mitochondrial swelling assay), followed by Newman-Keuls individual comparisons, using the NCSS 8 software package (NCSS, Kaysville, UT). The criterion for significance was P , 0.05.
RESULTS
Heart and Body Weights
There were no significant differences in heart or body weights between any of the groups at both time points (data not shown).
LV Tissue GSH and GSSG Levels
We first determined GSH and GSSG levels in LV tissues obtained in our previous experiments at time points from 2 h until 9 months after local heart irradiation (21 Gy single dose) in male Sprague-Dawley rats. A significant increase in GSSG levels caused a significant decrease in GSH/GSSG ratios in LV tissues at time points from 2 h to 10 weeks after local heart irradiation, indicative of prolonged oxidative stress (Supplementary Fig. S2 ; http://dx.doi.org/10.1667/ RR13915.1.S1). Because all natural forms of vitamin E are strong antioxidants, we determined the effects of TSB pretreatment on LV GSH/GSSG. Local heart irradiation caused a small but significant reduction in GSH/GSSG at 2 and 28 weeks, while the GSH/GSSG ratios in the TSBpretreated irradiated groups were not significantly different from the controls (Fig. 1) .
LV Tissue and Mitochondrial Protein Levels of Bax and Bcl2
Radiation caused a significant increase in the total LV expression of Bax at the 2 week time point and elevated Bax/Bcl2 ratios at both 2 and 28 weeks (Fig. 2A) . Increased LV Bax/Bcl2 ratios coincided with significant increases in mitochondrial Bax/Bcl2 ratios at both time points (Fig. 2B) . LV tissue and mitochondrial Bax/Bcl2 ratios in the TSBpretreated groups were not significantly different from vehicle-pretreated sham controls (Fig. 2) .
Mitochondrial Susceptibility to mPTP Opening and Changes in Mitochondrial Membrane Potential
Mitochondria isolated at 2 and 28 weeks postirradiation showed increased swelling in response to ex vivo stimulation with CaCl 2 (Fig. 3A) and doxorubicin (Supplementary Fig. S3 ; http://dx.doi.org/10.1667/RR13915.1.S1). Mitochondrial swelling was inhibited by CsA, confirming that it was due to mPTP opening. Moreover, reduced TMRM uptake indicated a reduced mitochondrial membrane potential at 2 weeks (Supplementary Fig. S3 ; http://dx.doi. org/10.1667/RR13915.1.S1). TSB pretreatment prevented calcium-and doxorubicin-induced mitochondrial swelling and maintained the mitochondrial membrane potential (Fig.  3 and Supplementary Fig. S3 ; http://dx.doi.org/10.1667/ RR13915.1.S1).
Mitochondrial Respiration
In agreement with the results from our previous work, we observed a reduction in state 2 respiration in mitochondria isolated at 2 weeks after irradiation and ex vivo analyzed in succinate-rotenone. TSB pretreatment protected against these radiation-induced changes (Fig. 4A) . No alterations were observed in mitochondrial respiration at 28 weeks after irradiation (Fig. 4B) . Lastly, as in our previous studies, mitochondrial respiration was not altered when glutamate-
FIG. 1.
Effects of radiation and TSB on LV GSH/GSSG ratios. TSB pretreatment maintained GSH/GSSG ratios in LV tissues at 2 weeks and 28 weeks after irradiation. Average 6 SEM, n ¼ 5-6. *P , 0.05 compared to sham-irradiated control.
malate was provided as substrates of complex I (data not shown).
LV Protein Levels of Cleaved Caspase 3
Increased Bax/Bcl2 ratios and mitochondrial membrane modifications may lead to induction of cleaved caspase 3. We observed a significant increase in cleaved caspase 3 at 2 and 28 weeks after irradiation. TSB pretreatment significantly reduced cleaved caspase 3 protein levels at both time points (Supplementary Fig. S4 ; http://dx.doi.org/10.1667/ RR13915.1.S1).
Ultrasound Parameters and Cardiac Remodeling
Because radiation-induced functional and histopathological changes are delayed effects of X irradiation, we performed ultrasound and histological analysis at the 28 week time point (Table 1) . Seven out of 10 irradiated animals showed bradycardia (heart rate ,250 bpm when under 1.5-2% isoflurane). Moreover, radiation caused a significant increase in total cardiac diameter, LVID and volume in diastole. Lastly, although irradiated hearts showed an increased stroke volume, irradiated hearts could not maintain cardiac output due to the reduced heart rate. None of the parameters were significantly modified by TSB (Table 1 ). In addition, TSB pretreatment enhanced the number of cardiac mast cells, but did not prevent radiationinduced cardiac fibrosis or reduced LV capillary density ( Fig. 5 and Supplementary Fig. S5 ; http://dx.doi.org/10. 1667/RR13915.1.S1).
DISCUSSION
In this study we tested the effects of a single oral dose of the tocotrienol-enriched formulation TSB on cardiac functional, histological and mitochondrial alterations at an TOCOTRIENOLS PROTECT CARDIAC MITOCHONDRIA FROM RADIATION early and late time point after local heart irradiation. While radiation-induced mitochondrial changes were prevented by TSB, no improvements were observed in cardiac function or histological parameters.
For this study, a single dose of radiation was examined. Therapeutic radiation is typically fractionated at 2 Gy per fraction. The effects of TSB treatment prior to fractionated irradiation remain to be determined.
It is well known that exposure to radiation results in the formation of reactive oxygen species (ROS) that cause oxidative damage of DNA, protein and lipids (28, 29) . This may lead to metabolic oxidative stress that contributes to the biological effects of radiation long after the time of exposure (30) . Glutathione plays an important role against radiation-induced oxidative damage (31) , and the ratio of reduced to oxidized glutathione serves as an index of the redox status of the cell. Because all natural forms of vitamin E are strong antioxidants, and reducing oxidative stress may therefore be one of the mechanisms by which TSB protects against mitochondrial changes, we examined the effects of TSB on the redox status of LV tissues after irradiation. First, we examined GSH/GSSG ratios in LV tissues obtained from a previous time-course study (5) . Radiation caused a prolonged and significant decrease in the GSH/GSSH ratios from 2 h to 10 weeks after irradiation, demonstrating prolonged radiation-induced oxidative stress in the heart. In TSB-pretreated hearts GSH/GSSG ratios were not significantly different from their sham counterparts. Although the differences between experimental groups were subtle, the results may suggest a long-term improvement in redox status with TSB pretreatment.
Under conditions of stress, levels of the pro-apoptotic Bax protein are increased relative to the anti-apoptotic Bcl2, and Bax is translocated to the outer mitochondrial membrane (32) (33) (34) (35) . Consistent with our previous studies (5), our current study shows the radiation-induced increases in Bax and Bax/Bcl2 ratios in total left ventricular protein lysates and in mitochondrial lysates. A single-dose administration   FIG. 3 . Effects of TSB pretreatment on radiation-induced mitochondrial susceptibility to mPTP opening. Susceptibility to mPTP opening in isolated mitochondria is examined by mitochondrial swelling, indicated by a reduction in the optical density at 540 nm (OD540nm) in response to CaCl 2 . The OD540nm of mitochondria in the swelling assay is expressed relative to the OD540nm of the same sample immediately before the start of the assay. Mitochondria are ex vivo exposed to the mPTP inhibitor CsA to confirm that swelling is due to mPTP opening. In vivo TSB pretreatment prevented mPTP opening in response to CaCl 2 in mitochondria isolated at both 2 and 28 weeks after local heart irradiation. Average 6 SEM, n ¼ 5. *P , 0.05 compared to shamirradiated control. # P , 0.05 compared to vehicle-pretreated irradiated.
of TSB 24 h before irradiation was effective in maintaining Bax/Bcl2 ratios at control levels. A recently published study also demonstrated the ability of c-tocotrienol to preserve the protein expression of Bax and decrease Bax/Bcl2 ratios in skin fibroblasts subjected to oxidative stress (36) . Insertion of Bax into the mitochondrial membrane is associated with increased mitochondrial membrane permeability and loss of membrane potential (37) . As described previously (5), a reduction in mitochondrial membrane potential was observed only at 2 weeks after irradiation. TSB pretreatment preserved the membrane potential in irradiated mitochondria.
Impaired mitochondrial function and altered Bax/Bcl2 ratios may eventually lead to activation of caspases and cellular apoptosis. We found that TSB pretreatment protected against radiation-induced increases in cleaved caspase 3 in the heart. Nonetheless, we have previously shown that local heart irradiation in our rat model does not lead to significant increases in the number of apoptotic cells (5), and we therefore believe that apoptosis may not play a significant role in the development of cardiac radiation injury in our model.
Mitochondrial permeability transition (MPT) is characterized by a loss of mitochondrial membrane potential, and mPTP opening in response to stimuli such as calcium, inorganic phosphate or ROS to induce mPTP opening (38) (39) (40) . We studied the opening of mPTP with a mitochondrial swelling assay. In accordance with our previous work, mitochondria isolated from irradiated hearts showed pronounced mitochondrial swelling in response to exogenous calcium. Here we also examined the effects of doxorubicin, a chemotherapeutic agent commonly used in combination with radiotherapy. Doxorubicin has profound cardiotoxic side effects that may be synergistic with radiation (41) . Although doxorubicin's cardiotoxicity is due in part to mitochondrial dysfunction (42) , previous studies have shown that under in vivo conditions doxorubicin alone did not induce mPTP opening (43) . Similarly, doxorubicin did not induce swelling in mitochondria isolated from sham-irradiated hearts in our study. On the other hand, mitochondria isolated from irradiated hearts did show significant doxorubicin-induced mPTP opening, suggesting that previous exposure to ionizing radiation made these mitochondria more susceptible to the effects of doxorubicin. Notes. High-resolution small animal ultrasound was used to determine cardiac function. Average 6 SEM, n ¼ 9-10. * P , 0.05 compared to sham-irradiated control.
Interestingly, a recent study showed that c-tocotrienol inhibited MPT and blocked mitochondrial membrane depolarization in oxidant-induced injury in renal proximal tubular cells (44) . TSB pretreatment prevented mPTP opening in response to both calcium and doxorubicin. These observations suggest that TSB may serve as an effective candidate to prevent mPTP opening in mitochondria induced by secondary stressors in the irradiated heart.
Previous studies have shown prolonged alterations in mitochondrial respiration in animal models of local heart irradiation. Barjaktarovic et al. reported decreased succinate-dependent respiration (state 2) with unaltered state 3 respiration in LV tissues of mouse hearts at 4 and 40 weeks after irradiation (45, 47). Franken et al. have shown significant reduction in state 3 respiration at 8 weeks after local heart irradiation in the rat with succinate and bhydroxybutyrate as ex vivo substrates (46) . In our approach, we examined oxygen flux in isolated mitochondria. We previously demonstrated reduced state 2 and state 4 respiration through complex II (succinate-dependent) with no alterations in respiration through complex I at 2 weeks after irradiation (5). In the current study, a single oral dose of TSB administered 24 h before irradiation significantly preserved the respiratory capacity in succinate-driven respiration at 2 weeks. Similarly, c-tocotrienol improves the state 3 respiration and function of the electron transport chain upon oxidant injury in primary cell cultures (44) .
We next studied whether TSB had effects on late cardiac function and remodeling. The rodent heart has a strong ability to compensate for myocardial structural damage to maintain cardiac output (48) . Nonetheless, in our experiment, due to a significantly reduced heart rate, cardiac output was not maintained despite a significant increase in stroke volume. A single oral dose of TSB 24 h before irradiation was not successful in preventing cardiac functional alterations. Adverse myocardial remodeling is a common manifestation of RIHD and coincides with increased cardiac mast cell numbers (49) . TSB did not protect against radiation-induced decrease in capillary density or collagen deposition and enhanced cardiac mast cell numbers.
Amifostine is currently the only approved radiation protector in radiation therapy, although it is not generally used because of its side effects. Amifostine was previously tested in rat models of local heart irradiation (50, 51) . Amifostine protected against radiation-induced myocardial degeneration (50) and cardiac function loss (51) , and was thereby more effective than the TSB administration in our model. While the effects of amifostine on cardiac fibrosis were small, macroscopic radiation injury in the lung was significantly reduced (51) . Therefore, it cannot be excluded that amifostine was protective by modifying heart-lung interactions (52) . However, in our model we do not administer a large enough dose of radiation to the lung to induce significant pulmonary inflammation or fibrosis.
From our studies it may be concluded that TSB pretreatment inhibited radiation-induced mitochondrial changes in the heart, including susceptibility to mPTP opening, reduced mitochondrial membrane potential, and reduced mitochondrial respiration as measured with ex vivo succinate-rotenone as the substrate. However, TSB pretreatment did not prevent radiation-induced long-term alterations in cardiac function and adverse cardiac remodeling. These findings suggest that changes in mitochondrial properties, as measured in this study, are not the main underlying mechanism of radiation toxicity in the heart. Repeated administration of tocotrienols may be more effective in reducing late manifestations of RIHD, by modifying additional contributing factors such as endothelial dysfunction.
FIG. 5.
Effects of TSB on cardiac remodeling at 28 weeks after irradiation. TSB did not modify a radiation-induced increase in LV collagen deposition (panel A) or decrease in capillary density (panel B). While radiation alone had no significant effect on cardiac mast cell numbers, TSB pretreatment significantly enhanced mast cell numbers in irradiated hearts (panel C). Average 6 SEM, n ¼ 9-10. *P , 0.05 when compared to sham-irradiated control. # P , 0.05 compared to vehicle-pretreated irradiated. Fig. S1 . Image-guided irradiation of the rat heart. Fig. S2 . HPLC analysis of reduced glutathione (GSH) and oxidized glutathione (GSSG) in left ventricles at 2 h to 9 months after local heart irradiation in adult male SpragueDawley rats. Fig. S3 . Effects of radiation and TSB on mitochondrial membrane properties. Fig. S4 . Effects of radiation and TSB on protein levels of cleaved caspase 3. Fig. S5 . Representative images of histological staining at 28 weeks after irradiation.
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